William Basri, MD
Gastroenterology · Brick, NJNPI 1992778948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 890 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 890 payments — averaging $14.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Bristol Myers Squibb$710
- Pfizer$654
- Madrigal Pharmaceuticals$608
- plus $4K from 29 others
Across 65 payments — averaging $4169.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Braintree Laboratories, Inc.$177K
- Pfizer$92K
- Amgen$2K
What the payments were for
- Speaking & faculty fees$200%
- Grants$200%
- Food & beverage$12,39895%
- Education$6115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 164 | $2,882 |
| AbbVie | 173 | $2,275 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 158 | $2,145 |
| Bristol Myers Squibb | 66 | $710 |
| Pfizer | 48 | $654 |
| Madrigal Pharmaceuticals | 42 | $608 |
| Gilead | 37 | $532 |
| Sanofi | 29 | $502 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $379 |
| Redhill Biopharma Inc. | 27 | $326 |
| QOL Medical, LLC | 19 | $321 |
| Lilly USA, LLC | 15 | $235 |
| Merck | 13 | $185 |
| Regeneron Healthcare Solutions, Inc. | 9 | $164 |
| Phathom Pharmaceuticals, Inc. | 8 | $130 |
| Daiichi Sankyo Inc. | 8 | $115 |
| Ironwood Pharmaceuticals, Inc | 6 | $91 |
| Hologic Sales And Service, LLC | 1 | $91 |
| Ferring Pharmaceuticals Inc. | 6 | $89 |
| Ardelyx, Inc. | 5 | $83 |
| Evoke Pharma, Inc. | 5 | $75 |
| Medtronic | 4 | $74 |
| Lucid Diagnostics Inc. | 1 | $66 |
| Romark Laboratories, LC | 3 | $54 |
| Braintree Laboratories, Inc. | 4 | $53 |
| Davol Inc. | 1 | $40 |
| Celltrion USA Inc. | 2 | $36 |
| Alfasigma USA, Inc. | 2 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Organon | 1 | $15 |
| Vivus LLC | 1 | $14 |
| Janssen Scientific Affairs, LLC | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,049 in reported general payments places this provider in the 90th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 18 | $537,176 |
| CreonLipase/Protease/Amylase | 41 | $130,704 |
| Humira(Cf) PenAdalimumab | 12 | $82,713 |
| LinzessLinaclotide | 45 | $45,012 |
| Dexlansoprazole DrDexlansoprazole | 35 | $18,172 |
| ViberziEluxadoline | 14 | $16,386 |
| TrulancePlecanatide | 18 | $12,681 |
| DexilantDexlansoprazole | 16 | $11,648 |
| Mesalamine | 57 | $10,616 |
| Sucralfate | 98 | $9,038 |
| Pantoprazole Sodium | 742 | $8,567 |
| Famotidine | 287 | $7,264 |
| Mesalamine DrMesalamine | 20 | $5,741 |
| CholestyramineCholestyramine (With Sugar) | 23 | $3,183 |
| Dicyclomine Hcl | 149 | $3,143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $2,882 | $537,17618 claims |
| AbbVieCreon, Linzess, Viberzi | $2,275 | $192,103100 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $2,145 | $12,68118 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $379 | $11,64816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 701 gastroenterology providers in New Jersey.
Other gastroenterology in Brick
- Mark CereficeBrick$25K
- Arkady BroderBrick$21K
- Kenny ChiuBrick$15K
- Kenny HuiBrick$15K
- Vinod RustgiNew Brunswick$431K
- Zamir BrelviNewark$391K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.